Granules India Limited — Others, 01-08-2025: News Verification

Granules India addressed market speculation regarding US government letters to global drug manufacturers seeking lower prices. The company unequivocally stated it has not received any such communication, nor is it among the 17 specific pharmaceutical companies mentioned in the White House press release. Granules India also confirmed there are no ongoing negotiations or legal proceedings related to this matter impacting them, and no undisclosed price-sensitive information. This clarification aims to ease investor concerns following recent stock movement, asserting that the general news affecting the pharma sector does not factually apply to Granules India's operations.